I had some email conversation with her as well and got a similar response. Between the lines she doesn't seem to be happy about the " big gap ".
Truth is, she can't be blamed for whatever Hopper has done or will do. At least is has been that way and only if she can establish any future influence on him regarding appreciating what the clinical people are doing things will change.
The 3 comps are run on these 3 principles:
1. I, Hopper, am the only one making the financial decisions.
2. You clinical experts make the clinical decisions.
3. Nobody interferes with the other side.
As long as both sides make the right decisions it works well. But if one side stuffs it up, that "Dictatorship" - model will fail. Now look at the financials and the sp of IMU, RAD and CHM as well as the clinical results and it becomes very obvious who is to blame.
Dalts, your rose coloured glases won't change that. Would be great if they could but facts are facts.
Get ready for the final nail.
GLTA
- Forums
- ASX - By Stock
- Ann: 2024 Annual Report update
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

I had some email conversation with her as well and got a similar...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $69.79K | 17.44M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 9548289 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.003 |
16 | 13800507 | 0.002 |
10 | 50600000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 9548289 | 12 |
0.005 | 14771167 | 22 |
0.006 | 13747410 | 16 |
0.007 | 4700000 | 4 |
0.008 | 8542434 | 6 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online